BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 7870747)

  • 1. Fluoxetine-induced sexual dysfunction: a dose-dependent effect?
    Benazzi F; Mazzoli M
    Pharmacopsychiatry; 1994 Nov; 27(6):246. PubMed ID: 7870747
    [No Abstract]   [Full Text] [Related]  

  • 2. Lack of sexual dysfunction with the selective noradrenaline reuptake inhibitor reboxetine during treatment for major depressive disorder.
    Clayton AH; Zajecka J; Ferguson JM; Filipiak-Reisner JK; Brown MT; Schwartz GE
    Int Clin Psychopharmacol; 2003 May; 18(3):151-6. PubMed ID: 12702894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of serotonin in sexual dysfunction: fluoxetine-associated orgasm dysfunction.
    Zajecka J; Fawcett J; Schaff M; Jeffriess H; Guy C
    J Clin Psychiatry; 1991 Feb; 52(2):66-8. PubMed ID: 1993638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluoxetine-induced sexual dysfunction reversed by trazodone.
    Michael A; O'Donnell EA
    Can J Psychiatry; 2000 Nov; 45(9):847-8. PubMed ID: 11143841
    [No Abstract]   [Full Text] [Related]  

  • 5. Fixed-dose fluoxetine therapy for depression.
    Wernicke JF; Dunlop SR; Dornseif BE; Zerbe RL
    Psychopharmacol Bull; 1987; 23(1):164-8. PubMed ID: 3496625
    [No Abstract]   [Full Text] [Related]  

  • 6. Switching to moclobemide to reverse fluoxetine-induced sexual dysfunction in patients with depression.
    Ramasubbu R
    J Psychiatry Neurosci; 1999 Jan; 24(1):45-50. PubMed ID: 9987207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluoxetine-induced reduction of body mass in patients with major depressive disorder.
    Harto NE; Spera KF; Branconnier RJ
    Psychopharmacol Bull; 1988; 24(2):220-3. PubMed ID: 3264922
    [No Abstract]   [Full Text] [Related]  

  • 8. Fluoxetine-induced sexual dysfunction.
    Herman JB; Brotman AW; Pollack MH; Falk WE; Biederman J; Rosenbaum JF
    J Clin Psychiatry; 1990 Jan; 51(1):25-7. PubMed ID: 2295587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What constitutes an adequate antidepressant trial for fluoxetine?
    Schweizer E; Rickels K; Amsterdam JD; Fox I; Puzzuoli G; Weise C
    J Clin Psychiatry; 1990 Jan; 51(1):8-11. PubMed ID: 2403998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeated observations of yawning, clitoral engorgement, and orgasm associated with fluoxetine administration.
    Modell JG
    J Clin Psychopharmacol; 1989 Feb; 9(1):63-5. PubMed ID: 2785122
    [No Abstract]   [Full Text] [Related]  

  • 11. The evidence for 20mg a day of fluoxetine as the optimal dose in the treatment of depression.
    Altamura AC; Montgomery SA; Wernicke JF
    Br J Psychiatry Suppl; 1988 Sep; (3):109-12. PubMed ID: 3074862
    [No Abstract]   [Full Text] [Related]  

  • 12. Fluoxetine and anorgasmia.
    Kline MD
    Am J Psychiatry; 1989 Jun; 146(6):804-5. PubMed ID: 2786344
    [No Abstract]   [Full Text] [Related]  

  • 13. Fluoxetine and desipramine in major depressive disorder.
    Bowden CL; Schatzberg AF; Rosenbaum A; Contreras SA; Samson JA; Dessain E; Sayler M
    J Clin Psychopharmacol; 1993 Oct; 13(5):305-11. PubMed ID: 8227488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse cutaneous reactions associated with fluoxetine strategy for reintroduction of this drug in selected patients.
    Leznoff A; Binkley KE; Joffee RT; Levitt A; Richter MA
    J Clin Psychopharmacol; 1992 Oct; 12(5):355-7. PubMed ID: 1479054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selegiline, fluoxetine, and depression in Parkinson's disease.
    Garcia-Monco JC; Padierna A; Gomez Beldarrain M
    Mov Disord; 1995 May; 10(3):352. PubMed ID: 7651457
    [No Abstract]   [Full Text] [Related]  

  • 16. Fluoxetine-tricyclic combinations.
    Zelwer A
    Aust N Z J Psychiatry; 1993 Jun; 27(2):350, 352. PubMed ID: 8363551
    [No Abstract]   [Full Text] [Related]  

  • 17. Single-dose fluoxetine in management of premenstrual syndrome.
    Daamen MJ; Brown WA
    J Clin Psychiatry; 1992 Jun; 53(6):210-1. PubMed ID: 1607351
    [No Abstract]   [Full Text] [Related]  

  • 18. Fluoxetine-induced sexual dysfunction and an open trial of yohimbine.
    Jacobsen FM
    J Clin Psychiatry; 1992 Apr; 53(4):119-22. PubMed ID: 1564046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement in fluoxetine-associated sexual dysfunction in patients switched to bupropion.
    Walker PW; Cole JO; Gardner EA; Hughes AR; Johnston JA; Batey SR; Lineberry CG
    J Clin Psychiatry; 1993 Dec; 54(12):459-65. PubMed ID: 8276736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Depression and sexual dysfunction: aspects of a multi-faceted relationship].
    Hartmann U
    Psychiatr Prax; 2007 Sep; 34 Suppl 3():S314-7. PubMed ID: 17786891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.